Speaker: Ross Levine, MD
Laurence Joseph Dineen Chair in Leukemia Research
Memorial Sloan-Kettering Cancer Center
New York, NY 10065
Topic: Genetics and Therapy of Myeloid Leukemia
Date: Tuesday, April 26, 2016
NEW Time: 12:00 p.m. – 1:00 p.m.
Location: 001 MSRB-1
Summary of Faculty Disclosure/Planning Committee
The following speakers and/or planning committee members have indicated they have relationship(s) with industry to disclose relative to the content of this CE activity: Ross Levine, MD, is on the Advisory Board for Loxo Oncology and CTI.
The following speakers and/or planning committee members have indicated they have relationship(s) with industry to disclose: Dr. Yiping Yang has indicated that he has no relationships with industry to disclose.
Joint Accreditation Statement
In support of improving patient care, Duke University Health System Department of Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.
Category 1*: Duke University Health System Department of Clinical Education and Professional Development designates this educational activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
It is the policy of the Duke University Health System Clinical Education and Professional Development to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity.
You must text the six letter code provided by the speaker to (919)213-8033 to receive credit for attending this conference.
- 1.00 AMA PRA Category 1 Credit(s)™